Skip to main content
Figure 2 | Trials

Figure 2

From: Optimization of the viability of stem cells derived from umbilical cord blood after maternal supplementation with DHA during the second or third trimester of pregnancy: study protocol for a randomized controlled trial

Figure 2

Work flow for the study. After recruitment the participants will be randomized into one of the two groups. Samples of venous blood will be taken from all participants before taking placebo or DHA (20th or 28th week) and at the 37th to 38th week of pregnancy to monitor the level of DHA. After birth, UCB samples will be collected and processed within 48 hours. DHA, docosahexaenoic acid; UCB, umbilical cord blood.

Back to article page

Trials

ISSN: 1745-6215